F8 and hemophilia A: This review provides a consolidated collection of the reported experiences of emicizumab-treated people with hemophilia A without FVIII inhibitors undergoing major surgery, and highlights that increased granularity of data collection and greater consistency in data reporting, arguably for any prophylaxis, on concomitant treatment and postoperative care are needed.